If you made any changes in Pure these will be visible here soon.

Research Output 1990 2019

Filter
Letter
2019
1 Citation (Scopus)
2 Citations (Scopus)

Serum and urinary macrophage migration inhibitory factor (MIF) in primary Sjögren's syndrome

Vincent, F. B., Lang, T., Kandane-Rathnayake, R. K., Downie-Doyle, S., Morand, E. F. & Rischmueller, M., 1 May 2019, In : Joint Bone Spine. 86, 3, p. 393-395 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren's syndrome

Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay, F., Morand, E. F. & Rischmueller, M., 1 May 2019, In : Clinical and Experimental Rheumatology. 37, 3, p. 254-256 3 p.

Research output: Contribution to journalLetterOtherpeer-review

Serum soluble Fas and Fas ligand (FasL) in primary Sjögren’s syndrome

Vincent, F. B., Bubicich, M., Downie-Doyle, S., Mackay-Fisson, F., Morand, E. F. & Rischmueller, M., 2019, (Accepted/In press) In : Clinical and Experimental Rheumatology. 3 p.

Research output: Contribution to journalLetterResearchpeer-review

2015
8 Citations (Scopus)

Remission in SLE: closing in on the target

van Vollenhoven, R. F., Voskuyl, A. E., Morand, E. F. & Aranow, C. B., 2015, In : Annals of the Rheumatic Diseases. 74, 12, p. 2103 - 2106 4 p.

Research output: Contribution to journalLetterOther

2014
1 Citation (Scopus)

Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?

Woolley, I. J., Ayoub, S., Crowe, S. M., Westhorpe, C. L., Cherry, C., Visvanathan, K. & Morand, E. F., 2014, In : AIDS. 28, 11, p. 1693 - 1694 2 p.

Research output: Contribution to journalLetterResearchpeer-review

Open Access
2004
1 Citation (Scopus)

Lower level of synovial fluid interferon-γ in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomais reactive arthritis (multiple letters) [7]

Cuchacovich, R., Espinoza, L. R., Bas, S., Gabay, C., Hoi, A. Y. & Morand, E. F., 1 Feb 2004, In : Rheumatology. 43, 2, p. 249-251 3 p.

Research output: Contribution to journalLetterOtherpeer-review

2003
9 Citations (Scopus)

Churg-Strauss syndrome: The use of cyclophosphamide in mononeuritis [7]

Hoi, A. Y. & Morand, E. F., 1 Feb 2003, In : Rheumatology. 42, 2, p. 390-391 2 p.

Research output: Contribution to journalLetterOtherpeer-review

Churg-Strauss syndrome: the use of cyclophosphamide in severe complications

Hoi, A. & Morand, E. F., 2003, In : Rheumatology. 42, p. 390 - 391 2 p.

Research output: Contribution to journalLetterOther

1995

Reply

Morand, E. F. & Hall, J., 1 Jan 1995, In : Arthritis & Rheumatism. 38, 5, p. 725-726 2 p.

Research output: Contribution to journalLetterOtherpeer-review

1994
9 Citations (Scopus)

Combination therapy with methotrexate and sulphasalazine in rheumatoid arthritis-tolerance of therapy

Axtens, R. S. K., Morand, E. F. & Lilejohn, G. O., 1 Jan 1994, In : Annals of the Rheumatic Diseases. 53, 10, 1 p.

Research output: Contribution to journalLetterOtherpeer-review